This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

5 Stocks Getting Ready to Pay Bigger Dividends

CVS Caremark

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

One billion: that's how many prescriptions pharmacy giant CVS Caremark (CVS) fills each year. There's safety in those numbers, at least for CVS shareholders. The firm has consistently outperformed its pure-play retail pharmacy peers, delivering enviable net profit margins and paying out a decent dividend throughout the financial roller coaster of 2007 and 2008. But CVS' income statement has grown faster than its dividend payout has -- and I think that the firm is ready to hike its 16.25-cent quarterly dividend.

>>5 Big Stock Charts You've Got to See to Believe

While CVS is best known to consumers for some 7,000 namesake retail pharmacies, the other part of the company's name comes from the 2007 acquisition of Caremark, a pharmacy benefit manager. Buying Caremark was a big deal for CVS -- it meant that the firm could suddenly avoid the somewhat adversarial relationship between PBMs and retail pharmacies. In essence, PBMs act as a middleman for pharmacies, stepping in between drugstores and drugmakers to source, package, and distribute pharmaceuticals in exchange for a markup along the way. Because CVS owns its own PBM, it doesn't have to fight over the size of that markup.

The introduction of MinuteClinics to many of CVS' store locations has provided another exciting growth avenue in the last few years, especially as consumers look for more cost-effective ways to get health treatments. Make no mistake: Right now, CVS' cash flows readily support a bigger dividend payout for investors.

CVS is one of Warren Buffett's holdings as of the most recently reported period.

3 of 6

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,172.68 -107.06 -0.62%
S&P 500 1,994.29 -16.11 -0.80%
NASDAQ 4,527.6890 -52.10 -1.14%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs